Anti EpCam PE - Analyte Specific Reagent. Anti-EpCAM is directed against human epithelial adhe...

FDA Device Recall #Z-1536-2014 — Class II — April 4, 2014

Recall Summary

Recall Number Z-1536-2014
Classification Class II — Moderate risk
Date Initiated April 4, 2014
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm BD Biosciences, Systems & Reagents
Location San Jose, CA
Product Type Devices
Quantity 12 for lot 3295974; 10 of lot 3259822

Product Description

Anti EpCam PE - Analyte Specific Reagent. Anti-EpCAM is directed against human epithelial adhesion molecule that has been identified as a 40 -kilodalton (kd) protein in Western Blotting.

Reason for Recall

Two lots of Anti EpCAM PE-Analyte Specific Reagent are mislabeled - the actual antibody present in the vial is CD9 PE.

Distribution Pattern

Worldwide Distribution-USA including the states of CA, TX, FL, MO, NY, MI, MO, and AZ and Seoul, Korea.

Lot / Code Information

Catalog number 347211; Lot number 3295974 - expiry date 2015-09-30; Lot number 3259822 - expiry date 2015-09-30.

Other Recalls from BD Biosciences, Systems & Reagents

Recall # Classification Product Date
Z-2090-2015 Class III BD Flow Cytometers; used on all BD FACSCount, B... Jun 15, 2015
Z-1375-2015 Class II CD123 (9F5) PE Catalog number 649453 Anal... Mar 23, 2015
Z-1370-2015 Class II BD FACSCalibur; Catalog Numbers 342973, 342975... Mar 6, 2015
Z-1000-2015 Class II CD8 (Leu-2a) PE (In vitro diagnostic), Catalog ... Dec 19, 2014
Z-1002-2015 Class II Anti-Lambda APC-H7, Catalog Number 656157. ... Dec 19, 2014

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.